• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YBX1通过提高人膀胱癌的糖酵解来促进肿瘤生长。

YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer.

作者信息

Xu Liuyu, Li Hongyun, Wu Longchao, Huang Shiming

机构信息

Department of Urology, QianFoShan Hospital Affiliated to Shandong University, Jinan 250014, P. R. China.

Department of Urology, Penglai People's Hospital of Shandong, Penglai 265600, P. R. China.

出版信息

Oncotarget. 2017 Jul 26;8(39):65946-65956. doi: 10.18632/oncotarget.19583. eCollection 2017 Sep 12.

DOI:10.18632/oncotarget.19583
PMID:29029484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5630384/
Abstract

Aerobic glycolysis, also known as Warburg effect, is a key hallmark of cancers. The Y-box-binding protein 1 (YBX1) is a well-known oncoprotein implicated in multiple malignant phenotypes of cancers. Meanwhile, little is known about the oncogenic functions and mechanisms of YBX1 in bladder cancer. Based on gene set enrichment analysis (GSEA) of TCGA RNAseq data, we find that YBX1 was profoundly involved in the glycolysis part of glucose metabolism. Loss- and gain-of-function studies show that YBX1 can enhance glycolysis as revealed by expression of glycolytic enzymes, glucose uptake, lactate secretion and extracellular acidification rate (ECAR). Inhibition of glycolysis completely compromises the tumor-promoting effect of YBX1 on tumor growth. Mechanistically, YBX1 regulates the expression of c-Myc and HIF1α, which further upregulate glycolytic enzymes to facilitate glycolysis. Moreover, study further confirms that genetic silencing of YBX1 markedly attenuates tumor growth and this tumor-suppressive effect is largely dependent on reduced glycolysis. Taken together, these results, as a proof of principle, provide a novel insight into the oncogenic role of YBX1 in glycolysis and suggest the potential therapeutic strategy by targeting YBX1 in bladder cancer.

摘要

有氧糖酵解,也称为瓦伯格效应,是癌症的一个关键特征。Y盒结合蛋白1(YBX1)是一种著名的癌蛋白,与癌症的多种恶性表型有关。与此同时,关于YBX1在膀胱癌中的致癌功能和机制知之甚少。基于对TCGA RNAseq数据的基因集富集分析(GSEA),我们发现YBX1深度参与了葡萄糖代谢的糖酵解部分。功能缺失和功能获得研究表明,YBX1可以增强糖酵解,这通过糖酵解酶的表达、葡萄糖摄取、乳酸分泌和细胞外酸化率(ECAR)得以体现。抑制糖酵解完全消除了YBX1对肿瘤生长的促进作用。从机制上讲,YBX1调节c-Myc和HIF1α的表达,进而上调糖酵解酶以促进糖酵解。此外,研究进一步证实,YBX1的基因沉默显著减弱肿瘤生长,这种肿瘤抑制作用很大程度上依赖于糖酵解的减少。综上所述,这些结果作为一个原理证明,为YBX1在糖酵解中的致癌作用提供了新的见解,并提示了针对膀胱癌中YBX1的潜在治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/b0329e82a11e/oncotarget-08-65946-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/3fd0ff7577e2/oncotarget-08-65946-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/90a234b5158c/oncotarget-08-65946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/e6a1e7b3c082/oncotarget-08-65946-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/321af20d17c1/oncotarget-08-65946-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/ed6409fc1f0b/oncotarget-08-65946-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/b0329e82a11e/oncotarget-08-65946-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/3fd0ff7577e2/oncotarget-08-65946-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/90a234b5158c/oncotarget-08-65946-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/e6a1e7b3c082/oncotarget-08-65946-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/321af20d17c1/oncotarget-08-65946-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/ed6409fc1f0b/oncotarget-08-65946-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da13/5630384/b0329e82a11e/oncotarget-08-65946-g006.jpg

相似文献

1
YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer.YBX1通过提高人膀胱癌的糖酵解来促进肿瘤生长。
Oncotarget. 2017 Jul 26;8(39):65946-65956. doi: 10.18632/oncotarget.19583. eCollection 2017 Sep 12.
2
HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.HMGA1 通过调节 c-myc 表达促进胃癌致癌和糖酵解表型。
Biochem Biophys Res Commun. 2019 Aug 20;516(2):457-465. doi: 10.1016/j.bbrc.2019.06.071. Epub 2019 Jun 19.
3
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.硫酸乙酰肝素酶-1(HSulf-1)缺乏决定了卵巢癌中糖酵解和三羧酸循环的代谢重编程。
Oncotarget. 2015 Oct 20;6(32):33705-19. doi: 10.18632/oncotarget.5605.
4
FOXJ1 promotes bladder cancer cell growth and regulates Warburg effect.FOXJ1促进膀胱癌细胞生长并调节瓦伯格效应。
Biochem Biophys Res Commun. 2018 Jan 1;495(1):988-994. doi: 10.1016/j.bbrc.2017.11.063. Epub 2017 Nov 10.
5
Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.药理学或遗传学抑制 LDHA 可逆转小儿骨肉瘤的肿瘤进展。
Biomed Pharmacother. 2016 Jul;81:388-393. doi: 10.1016/j.biopha.2016.04.029. Epub 2016 Apr 26.
6
SMYD2 suppresses p53 activity to promote glucose metabolism in cervical cancer.SMYD2 通过抑制 p53 活性促进宫颈癌中的葡萄糖代谢。
Exp Cell Res. 2021 Jul 15;404(2):112649. doi: 10.1016/j.yexcr.2021.112649. Epub 2021 May 17.
7
Metabolic phenotype of bladder cancer.膀胱癌的代谢表型。
Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8.
8
Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.致癌性 Y 框结合蛋白 1 作为耐药性癌症的有效治疗靶点。
Cancer Sci. 2019 May;110(5):1536-1543. doi: 10.1111/cas.14006. Epub 2019 Apr 7.
9
Role of post-translational modification of the Y box binding protein 1 in human cancers.Y盒结合蛋白1的翻译后修饰在人类癌症中的作用
Genes Dis. 2015 May 27;2(3):240-246. doi: 10.1016/j.gendis.2015.05.001. eCollection 2015 Sep.
10
The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer.c-Myc-LDHA轴正向调节有氧糖酵解并促进胰腺癌的肿瘤进展。
Med Oncol. 2015 Jul;32(7):187. doi: 10.1007/s12032-015-0633-8. Epub 2015 May 29.

引用本文的文献

1
Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification.膀胱癌:环状RNA在肿瘤发生、肿瘤抑制及治疗靶点识别中的作用
Cancer Genomics Proteomics. 2025 Sep-Oct;22(5):654-682. doi: 10.21873/cgp.20528.
2
YBX1: an RNA/DNA-binding protein that affects disease progression.YBX1:一种影响疾病进展的RNA/DNA结合蛋白。
Front Oncol. 2025 Jul 29;15:1635209. doi: 10.3389/fonc.2025.1635209. eCollection 2025.
3
RNA m5C modification: from physiology to pathology and its biological significance.

本文引用的文献

1
Contemporary update on neoadjuvant therapy for bladder cancer.膀胱癌新辅助治疗的当代进展。
Nat Rev Urol. 2017 Jun;14(6):348-358. doi: 10.1038/nrurol.2017.30. Epub 2017 Mar 14.
2
A Time for MYC: Metabolism and Therapy.MYC的时代:代谢与治疗
Cold Spring Harb Symp Quant Biol. 2016;81:79-83. doi: 10.1101/sqb.2016.81.031153. Epub 2017 Feb 7.
3
Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment.2016年膀胱癌:诊断、治疗及风险组评估方面的新进展
RNA m5C修饰:从生理到病理及其生物学意义
Front Immunol. 2025 Apr 30;16:1599305. doi: 10.3389/fimmu.2025.1599305. eCollection 2025.
4
Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer.溶瘤病毒疗法为鳞状细胞膀胱癌提供了一种有效的治疗选择。
Sci Rep. 2025 Apr 18;15(1):13443. doi: 10.1038/s41598-025-96419-3.
5
miR-379-5p Inhibited the Proliferation of Acute Myeloid Leukemia Cells Through Negative Regulation of .miR-379-5p通过对……的负调控抑制急性髓系白血病细胞的增殖。 (注:原文中“Through Negative Regulation of.”后面似乎缺失了具体内容)
Turk J Haematol. 2025 May 22;42(2):92-99. doi: 10.4274/tjh.galenos.2025.2024.0424. Epub 2025 Feb 24.
6
Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers.5-甲基胞嘧啶RNA结合蛋白的生物学功能及其在人类癌症中的潜在机制
Front Oncol. 2025 Feb 7;15:1534948. doi: 10.3389/fonc.2025.1534948. eCollection 2025.
7
PartIES: a disease subtyping framework with Partition-level Integration using diffusion-Enhanced Similarities from multi-omics Data.PARTIES:一种基于分区水平集成的疾病亚型框架,利用多组学数据的扩散增强相似性。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae609.
8
YB1 and its role in osteosarcoma: a review.YB1 及其在骨肉瘤中的作用:综述
Front Oncol. 2024 Oct 21;14:1452661. doi: 10.3389/fonc.2024.1452661. eCollection 2024.
9
Proteomic insights into breast cancer response to brain cell-secreted factors.蛋白质组学揭示乳腺癌对脑细胞分泌因子的反应
Sci Rep. 2024 Aug 21;14(1):19351. doi: 10.1038/s41598-024-70386-7.
10
KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.KMT2D 通过 H3K4me1 募集 YBX1,通过表观遗传激活 c-Myc 促进三阴性乳腺癌进展。
Clin Transl Med. 2024 Jul;14(7):e1753. doi: 10.1002/ctm2.1753.
Nat Rev Urol. 2017 Feb;14(2):74-76. doi: 10.1038/nrurol.2016.264. Epub 2017 Jan 4.
4
Cancer Metabolism: Fueling More than Just Growth.癌症代谢:不仅仅为生长提供能量
Mol Cells. 2016 Dec;39(12):847-854. doi: 10.14348/molcells.2016.0310. Epub 2016 Dec 29.
5
Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.Y盒结合蛋白1通过Wnt/β-连环蛋白信号通路促进肝癌起始细胞的进展和肿瘤发生。
Oncotarget. 2017 Jan 10;8(2):2604-2616. doi: 10.18632/oncotarget.13733.
6
The Warburg effect: 80 years on.瓦尔堡效应:80年过去了。
Biochem Soc Trans. 2016 Oct 15;44(5):1499-1505. doi: 10.1042/BST20160094.
7
YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.YBX1通过细胞周期蛋白依赖性激酶25A(CDC25a)途径调控人肺腺癌中的肿瘤生长。
Oncotarget. 2016 Dec 13;7(50):82139-82157. doi: 10.18632/oncotarget.10080.
8
Metabolic phenotype of bladder cancer.膀胱癌的代谢表型。
Cancer Treat Rev. 2016 Apr;45:46-57. doi: 10.1016/j.ctrv.2016.03.005. Epub 2016 Mar 8.
9
Energy disruptors: rising stars in anticancer therapy?能量干扰剂:抗癌治疗中的后起之秀?
Oncogenesis. 2016 Jan 18;5(1):e188. doi: 10.1038/oncsis.2015.46.
10
MYC and metabolism on the path to cancer.MYC与癌症发展过程中的新陈代谢
Semin Cell Dev Biol. 2015 Jul;43:11-21. doi: 10.1016/j.semcdb.2015.08.003. Epub 2015 Aug 12.